Results 271 to 280 of about 736,342 (305)
Some of the next articles are maybe not open access.
Journal of neuroradiology = Journal de neuroradiologie, 1990
The blood-brain barrier (BBB) is present on three sites: the brain vessels, the choroid plexus and the arachnoid membrane. It is made of non-fenestrated endothelial or epithelial cells interconnected by tight junctions. Biochemically, the BBB is formed by bimolecular layers of phospholipids into which globular proteins are inserted.
openaire +2 more sources
The blood-brain barrier (BBB) is present on three sites: the brain vessels, the choroid plexus and the arachnoid membrane. It is made of non-fenestrated endothelial or epithelial cells interconnected by tight junctions. Biochemically, the BBB is formed by bimolecular layers of phospholipids into which globular proteins are inserted.
openaire +2 more sources
A blood-brain barrier in a dish
Nature Methods, 2012Codifferentiating human pluripotent stem cells along neural and endothelial lineages provides cues to efficiently generate blood-brain barrier endothelial cells.
openaire +2 more sources
Astrocyte–endothelial interactions at the blood–brain barrier
Nature Reviews Neuroscience, 2006N. Abbott, L. Rönnbäck, E. Hansson
semanticscholar +1 more source
Blood-brain barrier biomarkers
The blood-brain barrier (BBB) is a dynamic interface that regulates the exchange of molecules and cells between the brain parenchyma and the peripheral blood. The BBB is mainly composed of endothelial cells, astrocytes and pericytes. The integrity of this structure is essential for maintaining brain and spinal cord homeostasis and protection from ...Juan F, Zapata-Acevedo +3 more
openaire +2 more sources
The blood-brain barrier in health and chronic neurodegenerative disorders.
Neuron, 2008B. Zlokovic
semanticscholar +1 more source
Drug Discovery Today, 2007
Neuropharmaceutics is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier (BBB). Essentially 100% of large-molecule drugs and >98% of small-molecule drugs do not cross the BBB. The BBB can be traversed because there are multiple endogenous transporters within this
openaire +2 more sources
Neuropharmaceutics is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier (BBB). Essentially 100% of large-molecule drugs and >98% of small-molecule drugs do not cross the BBB. The BBB can be traversed because there are multiple endogenous transporters within this
openaire +2 more sources
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
Pharmacological Reviews, 2005B. Hawkins, T. Davis
semanticscholar +1 more source